-
The current system of regulating community-based participatory research (CBPR) doesn't truly engage or protect communities as it should and fails to follow up on promises made by researchers to IRBs and to those whom they study, says one community researcher.
-
Some of the thorniest questions that IRBs face are those for which there are no clear-cut answers opinions may vary, arguments on both sides may be compelling, regulatory guidance may be scanty.
-
Large compensation to subjects for their participation in a study is considered a red flag by many IRBs, who worry that it could provide undue inducement to join a study without considering its risks.
-
While passive consent may not be the preferred way of obtaining parental permission to survey underage students, researchers say there will continue to be some situations in which it's the best and perhaps only practical choice.
-
When researchers want to survey underage students in school settings, it's obviously necessary to get permission from the children's parents. But exactly how that permission is best obtained has been a matter of debate.
-
Researchers at Temple University in Philadelphia, PA, have developed a novel approach to assessing the potential social risks to participants in a research study before the study commences.
-
Nationwide, research institutions are cutting costs in response to the economic downturn. Funding for education and training has been one area hit fairly hard, and this made it a challenge for IRB offices to meet their educational demands.
-
In this question-and-answer session, Mark Schreiner, MD, chair of the Committees for the Protection of Human Subjects (IRB) at the Children's Hospital of Philadelphia (CHOP) and an associate professor of anesthesia in pediatrics at the University of Pennsylvania in Philadelphia, PA, discusses the issue of informed consent in cluster-randomized clinical trials.
-
One chief hurdle in human research protection program (HRPP) accreditation is the mindset that its all about the IRB, an expert says.
-
While the informational quality of internationally registered trials has increased, theres still room for improvement, according to a recent study.